Literature DB >> 23419338

The usage of the Boussignac continuous positive airway pressure system in acute respiratory failure.

D T Wong1, A D Tam, T C R V Van Zundert.   

Abstract

Traditionally, continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) devices have been used to treat patients in acute respiratory failure. However they require an electric power source, are relatively large in size, and may be difficult to use in prehospital settings. The recently introduced Boussignac CPAP system is capable of delivering 10 cmH2O of CPAP, is compact, portable and requires only an oxygen source. This paper reviews the efficacy of using Boussignac CPAP as a treatment for acute respiratory failure in both prehospital and hospital settings. All studies mainly focused on patients treated for cardiogenic pulmonary edema. In the prehospital setting, Boussigac CPAP significantly improved respiratory parameters and oxygenation from baseline values. In the emergency department setting, Boussignac CPAP was more effective than standard oxygen delivery and just as effective as BiPAP in improving patient oxygenation and respiration. In one study, implementing Boussignac CPAP reduced intubation rate and hospital stay. Most hospital staff found Boussignac CPAP easy to use and complication rates were low. Boussigac CPAP is a useful device in the treatment of patients with acute respiratory failure, especially in the prehospital setting.

Entities:  

Mesh:

Year:  2013        PMID: 23419338

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  3 in total

1.  CPAP Added to Oxygen Administration Avoid Intubation in Acute Respiratory Distress in COVID-19 Pneumonia. Case Report.

Authors:  Gimbada Benny Mwenge; Daniel Rodenstein
Journal:  SN Compr Clin Med       Date:  2020-06-18

2.  Pre-hospital critical care management of severe hypoxemia in victims of Covid-19: a case series.

Authors:  Jens Otto Mæhlen; Roger Mikalsen; Hans Julius Heimdal; Marius Rehn; Jostein S Hagemo; William Ottestad
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-01-12       Impact factor: 2.953

3.  Management of critically ill COVID-19 patients: challenges and affordable solutions.

Authors:  Carlo Emanuele Caresia
Journal:  Pan Afr Med J       Date:  2021-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.